Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.
Balistreri WF, Murray KF, Rosenthal P, Bansal S, Lin CH, Kersey K, Massetto B, Zhu Y, Kanwar B, German P, Svarovskaia E, Brainard DM, Wen J, Gonzalez-Peralta RP, Jonas MM, Schwarz K. Balistreri WF, et al. Among authors: jonas mm. Hepatology. 2017 Aug;66(2):371-378. doi: 10.1002/hep.28995. Epub 2017 Jun 19. Hepatology. 2017. PMID: 27997679 Clinical Trial.
Clinical trial of lamivudine in children with chronic hepatitis B.
Jonas MM, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR, Greensmith MJ, Gardner SD, Bell MS, Sokal EM; International Pediatric Lamivudine Investigator Group. Jonas MM, et al. N Engl J Med. 2002 May 30;346(22):1706-13. doi: 10.1056/NEJMoa012452. N Engl J Med. 2002. PMID: 12037150 Free article. Clinical Trial.
Children with hepatitis C.
Jonas MM. Jonas MM. Hepatology. 2002 Nov;36(5 Suppl 1):S173-8. doi: 10.1053/jhep.2002.36799. Hepatology. 2002. PMID: 12407591 Review.
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics.
González-Peralta RP, Kelly DA, Haber B, Molleston J, Murray KF, Jonas MM, Shelton M, Mieli-Vergani G, Lurie Y, Martin S, Lang T, Baczkowski A, Geffner M, Gupta S, Laughlin M; International Pediatric Hepatitis C Therapy Group. González-Peralta RP, et al. Among authors: jonas mm. Hepatology. 2005 Nov;42(5):1010-8. doi: 10.1002/hep.20884. Hepatology. 2005. PMID: 16250032 Clinical Trial.
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group.
Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, Rosenthal P, Rodriguez-Baez N, Murray KF, Horslen S, Martin MG, Lopez MJ, Soriano H, McGuire BM, Jonas MM, Yazigi N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine JE, Karpen S, Ng V, Kelly D, Simonds N, Hynan LS. Squires RH Jr, et al. Among authors: jonas mm. J Pediatr. 2006 May;148(5):652-658. doi: 10.1016/j.jpeds.2005.12.051. J Pediatr. 2006. PMID: 16737880 Free PMC article.
Treatment of chronic hepatitis B in children.
Jonas MM. Jonas MM. J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S56-60. doi: 10.1097/01.mpg.0000226391.02355.1b. J Pediatr Gastroenterol Nutr. 2006. PMID: 16819403 Review.
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR, Schwarz KB. Goodman ZD, et al. Among authors: jonas mm. Hepatology. 2008 Mar;47(3):836-43. doi: 10.1002/hep.22094. Hepatology. 2008. PMID: 18167062 Free PMC article.
187 results